Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytosorbents Corp CTSO

Healthcare Medical Devices
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive... see more

Recent & Breaking News (NDAQ:CTSO)

CytoSorb® Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago

PR Newswire November 7, 2016

CytoSorbents Expands Direct Sales of CytoSorb to Belgium and Luxembourg

PR Newswire November 3, 2016

CytoSorbents to Report Q3 2016 Operating and Financial Results

PR Newswire November 1, 2016

CytoSorbents Congratulates Kathleen Bloch as NJBIZ Public Company Chief Financial Officer of the Year

PR Newswire October 17, 2016

CytoSorbents to Present at the 2016 BIO Investor Forum

PR Newswire October 14, 2016

CytoSorbents and Foxx Medical Begin Saving Lives in Chile with CytoSorb®

PR Newswire October 11, 2016

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  October 5, 2016

CytoSorbents Announces Positive Top-line Safety Data from REFRESH I Cardiac Surgery Trial

PR Newswire October 5, 2016

International Marketing of CytoSorb® Commences at European Association for Cardio-Thoracic Surgery Conference

PR Newswire Europe Non Regulatory October 3, 2016

New CytoSorbents Website Highlights Global Growth and Innovation

PR Newswire September 29, 2016

CytoSorbents Expands CytoSorb® into Iran with Partner Arsak

PR Newswire September 23, 2016

Mid-Morning Market Update: Markets Rise; Horizon Pharma To Buy Raptor Pharmaceutical For $9/Share

Benzinga.com  September 12, 2016

Terumo Cardiovascular Group and CytoSorbents Announce CytoSorb Cardiac Surgery Partnership

PR Newswire Europe Non Regulatory September 12, 2016

CytoSorbents Awarded $150,000 Phase I STTR Contract for Universal Plasma Development

PR Newswire June 22, 2016

CytoSorbents and Palex Bring CytoSorb® to Spain and Portugal

PR Newswire June 13, 2016

CytoSorbents Announces Fresenius Medical Care Initiates Sales of CytoSorb® in France, Poland and Scandinavia

PR Newswire June 1, 2016

Independent Data Safety Monitoring Board Recommends Continuation of CytoSorbents REFRESH I Trial

PR Newswire May 27, 2016

CytoSorb® Achieves Final Product Registration in Russia

PR Newswire May 18, 2016

CytoSorbents Continues Strong Growth in Q1 2016

PR Newswire May 9, 2016

CytoSorbents Establishes Swiss Subsidiary

PR Newswire May 6, 2016